Ketamine in treatment-resistant depression

Ketamine in treatment-resistant depression

Saved in:

Bibliographic Details
Main Authors:	Sana Dhamija, Suprakash Chaudhury, Bhushan Chaudhari
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-05-01
Series:	Industrial Psychiatry Journal
Online Access:	https://journals.lww.com/10.4103/ipj.ipj_17_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of ketamine in treatment-resistant depression
by: Joanna Dmochowska, et al.
Published: (2025-04-01)

Ketamine Cystitis Following Ketamine Therapy for Treatment Resistant Depression – Case Report
by: Minna Chang, et al.
Published: (2025-06-01)

Women and the workplace
by: Jyoti Prakash, et al.
Published: (2024-12-01)

Turner’s syndrome with schizophrenia: A case report
by: V Pooja, et al.
Published: (2025-01-01)

Camptocormia: A clinical enigma
by: Tahoora Ali, et al.
Published: (2025-01-01)

Secondary Personality Change in Traumatic Brain Injury
by: Dhrithi Mushthi, et al.
Published: (2024-11-01)

Sublingual Ketamine for Treatment Resistant Depression: Embracing the Change
by: Ranjini Rao
Published: (2025-06-01)

Personalized use of ketamine and esketamine for treatment-resistant depression
by: Gustavo C. Medeiros, et al.
Published: (2024-11-01)

Impact analysis of expanded access to ketamine for treatment-resistant depression
by: Thanh Lu, et al.
Published: (2025-05-01)

Effects of Ketamine vs. Midazolam in Adolescent Treatment Resistant Depression
by: Andrea Macejova, et al.
Published: (2024-12-01)

Intranasal racemic ketamine in treatment-resistant depression: Efficacy and tolerability in outpatient treatment
by: Jan Sarlon, et al.
Published: (2025-07-01)

Uniqueness of auditory hallucinations in patients with schizophrenia and depressive disorder
by: Tahoora Ali, et al.
Published: (2025-01-01)

Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
by: Sumaya Jobnah, et al.
Published: (2024-10-01)

Artificial intelligence in suicide prevention: Utilizing deep learning approach for early detection
by: Vikas Gaur, et al.
Published: (2024-12-01)

Inside the journey: A qualitative study of intravenous ketamine therapy for treatment-resistant depression
by: Jason Perepelkin, et al.
Published: (2025-04-01)

Ketamine in Prevention and Treatment of Postpartum Depression - Literature Review
by: Daria Stefaniak, et al.
Published: (2025-03-01)

Predicting treatment response to ketamine in treatment-resistant depression using auditory mismatch negativity: Study protocol.
by: Josh Martin, et al.
Published: (2024-01-01)

Ketamine treatment for depression in elderly inpatients: an observational case series
by: Benedikt Römer, et al.
Published: (2025-04-01)

Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant depression: a naturalistic feasibility study
by: Katelyn Halpape, et al.
Published: (2025-01-01)

Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms
by: Piotr Kawczak, et al.
Published: (2024-10-01)

Effects of ketamine treatment on suicidal ideation: a qualitative study of patients’ accounts following treatment for depression in a UK ketamine clinic
by: Keith Hawton, et al.
Published: (2019-08-01)

Corrigendum: Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression
by: Weronika Dębowska, et al.
Published: (2024-10-01)

A Comparative Study on the Effectiveness of Electroconvulsive Therapy and Ketamine in Persons Suffering from Treatment-resistant Depressive Disorder
by: Vikhram Ramasubramanian, et al.
Published: (2024-12-01)

Long-Term Effects of Single and Repeated Ketamine Infusions on Treatment-Resistant Depression: A Retrospective Chart Review Study
by: Sofia Sakopoulos, et al.
Published: (2024-10-01)

Bioactive ketamine metabolite exerts in vivo neuroplastogenic effects to improve hippocampal function in a treatment-resistant depression model
by: Lace M. Riggs, et al.
Published: (2025-06-01)

Depression and Anxiety following Coronary Artery Bypass Graft: Current Indian Scenario
by: Suprakash Chaudhury, et al.
Published: (2016-01-01)

Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression
by: Nicole R. Silva, et al.
Published: (2025-01-01)

Evaluation of neuroplastic changes in the prefrontal cortex following ketamine administration to patients with treatment-resistant depression assessed by paired association stimulation
by: Keita Taniguchi, et al.
Published: (2025-01-01)

The interactive effects of ketamine and magnesium upon depressive-like pathology
by: Razmjou S, et al.
Published: (2016-09-01)

Research Progress on the Mechanism of Ketamine in Neuropathic Pain Comorbid Depression
by: Li Q, et al.
Published: (2025-08-01)

Heterogenic bacterial resistance to low concentration of ketamine
by: Tomasz Jarzembowski, et al.
Published: (2024-12-01)

Modulation of ER Stress and Inflammation by S-Ketamine, R-Ketamine, and Their Metabolites in Human Microglial Cells: Insights into Novel Targets for Depression Therapy
by: Marta Jóźwiak-Bębenista, et al.
Published: (2025-06-01)

Depression, anxiety, and suicidal ideation in college students in the aftermath of COVID-19 pandemic
by: Parisha Kelker, et al.
Published: (2025-05-01)

Role of Ketamine in the Treatment of Psychiatric Disorders
by: Sahar Derakhshanian, et al.
Published: (2021-06-01)

Rehabilitation after Amputation: Psychotherapeutic Intervention Module in Indian Scenario
by: Kalpana Srivastava, et al.
Published: (2014-01-01)

Pentazocine and zolpidem addiction in a sickle cell anemia patient
by: Mandakini Bhowmick, et al.
Published: (2024-12-01)

Cognitive Biases Causing Road-Traffic Accidents
by: Dhrithi Mushthi, et al.
Published: (2024-11-01)

Case Report of Subanesthetic Intravenous Ketamine Infusion for the Treatment of Neuropathic Pain and Depression with Suicidal Features in a Pediatric Patient
by: Garret Weber, et al.
Published: (2018-01-01)

Effect of ketamine and esketamine on RNA expression and its relevance for depression: A systematic review
by: Claudia Pisanu, et al.
Published: (2025-09-01)

S‐ketamine Alleviates Neuroinflammation and Attenuates Lipopolysaccharide‐Induced Depression Via Targeting SIRT2
by: Cong Lin, et al.
Published: (2025-06-01)